Basic Information (Switzerland) Elecon Asia SA (hereinafter referred to as “Elecon”) is a powerful intelligent three-d...
Digital Copyright Ten Major Typical Cases 1.Short Video Copyright Case: Whether a Short Video is Original Has Nothing to...
December 7, 2023 - News of a patent infringement ruling against Apple Watches a few weeks ago caused a flurry of investo...
The Korea Intellectual Property Office recently released authoritative data showing that the total number of patent applications in South Korea reached 260,797 in 2025, an increase of 5.9% compared
According to an order of the Düsseldorf local division, the parties have now settled (case ID: UPC_CFI_504/2023). The details of the settlement are not known. However, according to JUVE Patent sources
and demanded a PI, it filed an action for infringement of EP 533, EP 986, EP 066 and GB patent 2 510 725 at the UK High Court (case ID: HP-2025-000037). Guardant is seeking a permanent injunction
streaming service, which considers DivX's patents invalid. Now the dispute moves to the UPC. In September, the German Federal Court of Justice dismissed DivX’s appeal against the Federal Patent Court’s
Chinese access control leader Hongmen Advanced Technology Corporation is now involved in a new patent dispute with its industry rival Shenzhen Jieshun Science and Technology Industry Co., Ltd.
infringes a patent held by Fresenius Kabi, thus overturning a first-instance decision. Fresenius Kabi alleges that Biogen’s Imraldi has infringed its EP 3 145 488 B1 for a ‘liquid pharmaceutical
Chinese cloud-computing giant Inspur has withdrawn its patent invalidity challenges against Hewlett Packard Enterprise (HPE), signaling a potential shift in the ongoing cross-border intellectual
Brazil has kept up its efforts to improve the protection and enforcement of IPR over the reporting period. The Brazilian IPR Office (INPI) continues reducing the patent and trade mark backlogs. INPI
The dental equipment industry is seeing increasingly fierce patent disputes. Several manufacturers are facing off in court. Now, the Higher Regional Court in Düsseldorf has dismissed a lawsuit filed
ToolGen’s EP 4 357 457 patent covering CRISPR-Cas9 RNP technology. EP 457 is a divisional patent of EP 4 397 759. Vertex, for whom Lonza manufactures the drug, had apparently anticipated this move.
CHINA intellectual PROPERTY LAWYERS NETWORK
+86-13910160652
ciplawyers@163.com
